恩华药业 (002262)

Jiangsu Nhwa Pharmaceutical Co.，LTD

ASZ

Tags

AI HealthcareMSCI Mid Cap IndexGeneric DrugsInnovation 100 IndexInnovative DrugsPharmaceutical ManufacturingSustainable GrowthSmart HealthcareSocial Security Fund Heavy PositionsHigh-Performing StocksMargin Trading and Securities LendingSME 100 IndexSME 300 IndexSZSE 300 IndexSZSE Innovation IndexTech 100 Index

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 101578.66
  • Circulating A-Shares(W): 88390.85
  • Earnings Per Share(RMB): 1.0900
  • Net Assets Per Share(RMB): 7.9779
  • Operating Revenue(W RMB): 447098.88
  • Total Profit(W RMB): 123355.72
  • Net Profit Attributable to Parent(W RMB): 110604.74
  • Net Profit Growth Rate(%): 8.42
  • Weighted Return on Equity(%): 14.3100
  • Operating Cash Flow Per Share(RMB): 0.8970
  • Undistributed Profit Per Share(RMB): 6.2711
  • Capital Reserve Per Share(RMB): 0.2730

2. Main Business

The main business covers:

  • Pharmaceutical R&D, production, and sales

3. Company Basic Information

  • Company Name: Jiangsu Nhwa Pharmaceutical Co., Ltd.
  • Listing Date: 2008-07-23
  • Industry: Pharmaceutical Manufacturing
  • Address: Nhwa Technology Building, No.31 Longhu West Road, Economic and Technological Development Zone, Xuzhou City, Jiangsu Province
  • Website: www.nhwa-group.com
  • Company Profile: The company was established as a joint-stock company through the overall change of the audited net assets of Jiangsu Nhwa Pharmaceutical Group Co., Ltd. as of December 31, 2006. On April 29, 2007, the company was legally registered and approved by the Xuzhou Administration for Industry and Commerce, obtaining the "Business License of Enterprise Legal Person" with registration number 3203002112097. The registered capital was 90 million yuan, with a par value of RMB 1.00 per share, and the legal representative is Sun Pengsheng.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Xuzhou Nhwa Investment Co., Ltd. General Legal Person 32009.63 36.21
2 Hong Kong Securities Clearing Company Ltd. Northbound Capital 1328.84 1.50
3 National Social Security Fund 101 Portfolio Social Security Fund 1242.85 1.41
4 National Social Security Fund 413 Portfolio Social Security Fund 940.18 1.06
5 Penghua Optimal Value Stock Securities Investment Fund Class A Fund 385.01 0.44
6 Southern Medical Healthcare Flexible Allocation Hybrid Securities Investment Fund Class A Fund 285.72 0.32
7 Dacheng Consumption Theme Hybrid Securities Investment Fund Class A Fund 200.07 0.23
8 Dacheng Jingyang Leading Hybrid Securities Investment Fund Class A Fund 135.74 0.15
9 Dacheng Yuanchen Zhaoli Bond Securities Investment Fund Class A Fund 125.96 0.14
10 Dacheng Positive Growth Hybrid Securities Investment Fund Class A Fund 118.92 0.13

5. Concept Sectors

  • Smart Healthcare
  • Generic Drugs
  • Innovative Drugs
  • AI Healthcare
  • Margin Trading & Securities Lending
  • High-Performance Stocks
  • Social Security Fund Heavy Holdings
  • Sustained Growth
  • MSCI Mid Cap
  • SME 100
  • SZSE 300
  • Technology 100
  • SME 300
  • SZSE Innovation
  • Innovation 100

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information